Pharmaceuticals & Biologics

Extractables and leachables: definitions, differences & facts

Extractables and leachables: definitions, differences & facts Extractables and leachables are contaminants that are causing biopharmaceutical manufacturers headaches, as they…

11 months ago

Visible Particles in Parenteral Drug Products: A Review of Current Safety Assessment Practice

Visible Particles in Parenteral Drug Products: A Review of Current Safety Assessment Practice Visible particles (VPs) in parenteral drug products…

11 months ago

The Role of Statistics in Clinical Trials: Safeguarding Patient Safety and Improving Healthcare Outcomes through Rigorous Evaluation of Medical Treat.

Introduction:  Clinical trials are essential for evaluating the safety and efficacy of new medical treatments. They provide a rigorous framework…

11 months ago

Why DQ, IQ, OQ, PQ Are Mandatory in Quality Assurance: Why It’s Essential and How to Handle It

Why DQ, IQ, OQ, PQ Are Mandatory in Quality Assurance: Why It’s Essential and How to Handle It? By :Dr.…

11 months ago

Cleaning Validation and Verification Reporting: A Mandatory QA Requirement

Cleaning Validation and Verification Reporting: A Mandatory QA Requirement By :Dr. Dhriti Tupe, GxP Expert ® Introduction In pharmaceutical manufacturing, ensuring…

11 months ago

Handling Elemental Impurities Risk Assessments in Pharmaceuticals

Handling Elemental Impurities Risk Assessments in Pharmaceuticals By :Dr. Dhriti Tupe, GxP Expert ® A Comprehensive Guide Elemental impurities in…

11 months ago

Leading Hidradenitis Suppurativa Treatments in the Market

Leading Hidradenitis Suppurativa Treatments in the Market Currently, some of the top medications for treating hidradenitis suppurativa (HS) include BIMZELX…

11 months ago

Exploring Pharmacokinetic (PK) Data and Strategies for Analysis

Some basics of Pharmacokinetics (PK) analysis: Pharmacokinetics refers to the study of how a drug is absorbed, distributed, metabolized, and eliminated…

11 months ago

Bristol Myers Squibb Advances Opdualag to Phase 3 Trials for Non-Small Cell Lung Cancer

Bristol Myers Squibb Advances Opdualag to Phase 3 Trials for Non-Small Cell Lung Cancer Bristol Myers Squibb (BMS) is set…

11 months ago

Keytruda’s Triumph in Early-Stage Triple-Negative Breast Cancer: A New Standard of Care

Keytruda's Triumph in Early-Stage Triple-Negative Breast Cancer: A New Standard of Care Merck's Keytruda (pembrolizumab) has achieved a significant milestone…

11 months ago